Adjunctive Isradipine for the Treatment of Bipolar Depression

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study investigates the medication isradipine, which is currently approved by the FDA to treat high blood pressure, in the treatment of depression in bipolar disorder. Isradipine or placebo (contains no active medication) will be used as an \"add-on\" to lithium, valproate, and/or atypical antipsychotics for individuals currently experiencing a major depressive episode. Our hypothesis is that isradipine will be superior to placebo in improving depressive symptoms.
Epistemonikos ID: fd144f30c03b3c23547a2f9ce73e8643f1894e0d
First added on: May 11, 2024